Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for August 19th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 19th:

Advanced Drainage Systems, Inc. (WMS - Free Report) : This company that designs, manufactures, and markets thermoplastic corrugated pipes and related water management products carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 58.8% over the last 60 days.

Advanced Drainage Systems has a PEG ratio of 0.51 compared with 1.68 for the industry. The company possesses a Growth Score of A.

Meritage Homes Corporation (MTH - Free Report) : This company that designs and builds single-family homes carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 53.9% over the last 60 days.

Meritage Homes has a PEG ratio of 0.61, compared with 1.25 for the industry. The company possesses a Growth Score of A.

Sanmina Corporation (SANM - Free Report) : This company that provides integrated manufacturing solutions, components, products and repair, logistics, and after-market services carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.7% over the last 60 days.

Sanmina Corp. has a PEG ratio of 0.84, compared with 1.90 for the industry. The company possesses a Growth Score of B.

Owens & Minor, Inc. (OMI - Free Report) : This healthcare solutions company carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Owens & Minor has a PEG ratio of 0.48, compared with 1.55 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>